David N. Gordon, Chief Medical Officer at Aclaris Therapeutics, Inc. (ACRS), sold 2,631 shares at $16.98 ($45K) on 2021-07-13, disclosed to the SEC on 2021-07-14.
Open-market sale of $45k ACRS by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.